Brain Cancer
Targeting clonal heterogeneity in treatment-refractory glioblastoma with novel and empiric immunotherapies
A newly funded TFRI “dream team” plans to tackle the most lethal and aggressive brain tumour that occurs in adults by focusing not on the original tumour, but on the relapsed cancer.
&ldqu...
Read More